Hear Brent A. Neuschwander-Tetri, MD, explore NASH screening and the interplay among NAFLD, metabolic syndrome, CV risk, and diabetes risk, including:

Should We Screen for NASH?Role of obesity and type 2 diabetes mellitusCardiovascular Risk in NAFLD/NASHHow to Evaluate for NAFLD/NASHBiomarkersImagingWhen/whom to biopsy?Management in Multidisciplinary Settings

Download the slides from this podcast at:
https://bit.ly/2ZBvVvy

See more NASH topics at:
https://bit.ly/3ezkBq6